These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Losartan in patients with renal insufficiency. de Zeeuw D; Gansevoort RT; de Jong PE Can J Cardiol; 1995 Aug; 11 Suppl F():41F-44F. PubMed ID: 7664217 [TBL] [Abstract][Full Text] [Related]
5. [The medicine of the month. Losartan (Cozaar)]. Scheen AJ Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640 [No Abstract] [Full Text] [Related]
6. A new class of antihypertensive: angiotensin II receptor antagonists. McCoy R S D J Med; 1995 Sep; 48(9):319-20. PubMed ID: 7481726 [No Abstract] [Full Text] [Related]
7. Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease. Gansevoort RT; de Zeeuw D; Shahinfar S; Redfield A; de Jong PE J Hypertens Suppl; 1994 Jul; 12(2):S37-42. PubMed ID: 7965264 [TBL] [Abstract][Full Text] [Related]
9. Losartan: the first angiotensin receptor antagonist in clinical use. Beevers DG J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475 [No Abstract] [Full Text] [Related]
10. Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension. Tsunoda K; Abe K; Hagino T; Omata K; Misawa S; Imai Y; Yoshinaga K Am J Hypertens; 1993 Jan; 6(1):28-32. PubMed ID: 8427658 [TBL] [Abstract][Full Text] [Related]
11. Successful long-term treatment of post-transplant erythrocytosis with losartan. Midtvedt K; Stokke ES; Hartmann A Nephrol Dial Transplant; 1996 Dec; 11(12):2495-7. PubMed ID: 9017632 [No Abstract] [Full Text] [Related]
12. Synthesis and angiotensin II receptor antagonist activity of C-linked pyrazole derivatives. Nicolaï E; Curé G; Goyard J; Kirchner M; Teulon JM; Versigny A; Cazes M; Virone-Oddos A; Caussade F; Cloarec A Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1617-30. PubMed ID: 7954914 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II antagonism: a new avenue of hypertension management. Gavras H Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108 [TBL] [Abstract][Full Text] [Related]
14. Angioedema associated with angiotensin II receptor antagonist losartan. Sharma PK; Yium JJ South Med J; 1997 May; 90(5):552-3. PubMed ID: 9160080 [TBL] [Abstract][Full Text] [Related]
15. Brief report: acute renal failure after losartan treatment in a patient with bilateral renal artery stenosis. Holm EA; Randløv A; Strandgaard S Blood Press; 1996 Nov; 5(6):360-2. PubMed ID: 8973754 [No Abstract] [Full Text] [Related]
16. Reversible ageusia associated with losartan. Schlienger RG; Saxer M; Haefeli WE Lancet; 1996 Feb; 347(8999):471-2. PubMed ID: 8618505 [No Abstract] [Full Text] [Related]
17. Losartan: a new antihypertensive drug. Dubois M; Wilson TW Can Nurse; 1997 Jun; 93(6):31-4. PubMed ID: 9233121 [TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive effect of a non-peptide angiotensin II receptor antagonist, MK954, in patients with essential hypertension]. Hagino T; Abe K; Tsunoda K; Yoshinaga K Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):133-40. PubMed ID: 1588765 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptors and angiotensin II receptor antagonists. Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104 [No Abstract] [Full Text] [Related]
20. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade? Brunner HR J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462 [No Abstract] [Full Text] [Related] [Next] [New Search]